Related Experiment Video
Updated: Jul 17, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis
Geurt Schilders1, Reinout Raijmakers, Kelen C R Malmegrim
1Department of Biomolecular Chemistry, Nijmegen Center for Molecular Life Sciences, Institute for Molecules and Materials, Radboud University Nijmegen, Geert Grooteplein 26-28, Nijmegen, 6525 GA, The Netherlands. g.schilders@ncmls.ru.nl
Abstract:
Recent studies have implicated the dying cell as a potential reservoir of modified autoantigens that might initiate and drive systemic autoimmunity in susceptible hosts. A number of subunits of the exosome, a complex of 3'-->5' exoribonucleases that functions in a variety of cellular processes, are recognized by the so-called anti-PM/Scl autoantibodies, found predominantly in patients suffering from an overlap syndrome of myositis and scleroderma. Here we show that one of these subunits, PM/Scl-75, is cleaved during apoptosis. PM/Scl-75 cleavage is inhibited by several different caspase inhibitors. The analysis of PM/Scl-75 cleavage by recombinant caspase proteins shows that PM/Scl-75 is efficiently cleaved by caspase-1, to a smaller extent by caspase-8, and relatively inefficiently by caspase-3 and caspase-7. Cleavage of the PM/Scl-75 protein occurs in the C-terminal part of the protein at Asp369 (IILD369 [see text] G), and at least a fraction of the resulting N-terminal fragments of PM/Scl-75 remains associated with the exosome. Finally, the implications of PM/Scl-75 cleavage for exosome function and the generation of anti-PM/Scl-75 autoantibodies are discussed.
Insights
Dying cells release modified autoantigens, potentially causing autoimmunity. Researchers found that the exosome subunit PM/Scl-75 is cleaved during apoptosis by caspases, impacting autoimmunity.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Dying cells can harbor modified autoantigens, initiating autoimmunity in susceptible individuals.
- Anti-PM/Scl autoantibodies target exosome subunits and are prevalent in myositis and scleroderma overlap syndrome.
Purpose of the Study:
- To investigate the cleavage of the exosome subunit PM/Scl-75 during apoptosis.
- To determine the role of caspases in PM/Scl-75 cleavage and its implications for autoimmunity.
Main Methods:
- Studied apoptosis-induced cleavage of PM/Scl-75.
- Utilized caspase inhibitors and recombinant caspase proteins (caspase-1, -8, -3, -7) to analyze cleavage sites and efficiency.
- Examined the association of PM/Scl-75 fragments with the exosome.
Main Results:
- PM/Scl-75 is cleaved during apoptosis, a process inhibited by caspase inhibitors.
- Caspase-1 and caspase-8 are the primary caspases responsible for PM/Scl-75 cleavage.
- Cleavage occurs at Asp369, generating N-terminal fragments that remain associated with the exosome.
Conclusions:
- Apoptotic cleavage of PM/Scl-75 by specific caspases may contribute to the generation of anti-PM/Scl autoantibodies.
- This cleavage could impact exosome function and play a role in the pathogenesis of systemic autoimmune diseases.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy

